One stock that might be an intriguing choice for investors right now is BioTime, Inc. BTX. This is because this security in the Medical-Biomedical/Genetics space is seeing solid earnings estimate ...

BlackRock Technology and Private Equity Term Trust's (BTX) current share price is $6.28. This constitutes a price movement of 8.32% when compared to the share price 7 days ago and is -20.10% below BTX ...

BlackRock, an investment management company, released its fourth-quarter 2025 investor letter for the “BlackRock Technology and Private Equity Term Trust”. A copy of the letter can be downloaded here.

In trading on Tuesday, shares of Blackrock Technology and Private Equity Term Trust (Symbol: BTX) crossed above their 200 day moving average of $7.26, changing hands as high as $7.28 per share.

BlackRock, an investment management company, released its fourth-quarter 2025 investor letter for the “BlackRock Technology and Private Equity Term Trust”. A copy of the letter can be downloaded here.

Brooklyn ImmunoTherapeutics, Inc. (BTX) is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment, leveraging its proprietary technology platforms.

BlackRock Technology Stock Short Interest Report | NYSE:BTX | Benzinga Short interest in BlackRock Technology and Private Equity Term Trust (NYSE:BTX) decreased during the last reporting period, ...

As part of an updated Tender Offer and strategy change, the name and ticker symbol of the BlackRock Innovation & Growth fund (BIGZ) has changed to the BlackRock Technology & Private Equity Fund (BTX), ...

Get the latest news and real-time alerts from BlackRock Technology and Private Equity Term Trust (BTX) stock at Seeking Alpha. | Page 2 ...